MAHESH HARSHAD BHUTA's Insider Trades & SAST Disclosures
MAHESH HARSHAD BHUTA's most recent trade in Jenburkt Pharmaceuticals Ltd. was a Acquisition of 29,412 Equity Shares done . Disclosure was reported to the exchange on Oct. 3, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for MAHESH HARSHAD BHUTA in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jenburkt Pharma | MAHESH HARSHAD BHUTA | Promoter Group | Acquisition | 03 Oct 2022 | 29,412 | 74,374 (1.62%) | 0.64% | 0 | 0 | 23 Sep 2022 30 Sep 2022 |
Insider Trading | Equity Shares | Off Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.